Medicine guide

Zonisamide Viatris (previously Zonisamide Mylan)

·

  • Prescription status not stated
  • Pain, sleep, mood, epilepsy and the brain
Active substance
Zonisamide
Made by
Viatris Limited

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy; adjunctive therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents, and children aged 6 years and above.

From the official label · 2026-09-30 · European Medicines Agency

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

BulgariaNo exact match for this strength and form

SpainNo exact match for this strength and form

FranceNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byViatris Limited
Active substanceZonisamide
Used inPain, sleep, mood, epilepsy and the brain
ClassificationN03AX15 · Pain, sleep, mood, epilepsy and the brain
GenericYes — a generic medicine, according to the register
Authorised on2016-03-31
Last updated by the regulator2026-09-14
EMA product numberEMEA/H/C/004127

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.